Cargando…

Health and economic impact of delaying large-scale HPV vaccination and screening implementation on cervical cancer in China: a modelling study

BACKGROUND: Current uptake of HPV vaccination and screening in China is far below World Health Organization 2030 targets for cervical cancer elimination. We quantified health and economic losses of delaying large-scale HPV vaccination and screening implementation in China. METHODS: We used a previou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gao, Meng, Hu, Shangying, Zhao, Xuelian, You, Tingting, Jit, Mark, Liu, Yang, Qiao, Youlin, Zhao, Fanghui, Wang, Chen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398607/ https://www.ncbi.nlm.nih.gov/pubmed/37547038 http://dx.doi.org/10.1016/j.lanwpc.2023.100768

Ejemplares similares

Optimal allocation strategies for HPV vaccination introduction and expansion in China accommodated to different supply and dose schedule scenarios: A modelling study
por: You, Tingting, et al.
Publicado: (2022)

Effectiveness and cost-effectiveness of eliminating cervical cancer through a tailored optimal pathway: a modeling study
por: Xia, Changfa, et al.
Publicado: (2021)

High-risk HPV nucleic acid detection kit–the careHPV test –a new detection method for screening
por: Ying, Hong, et al.
Publicado: (2014)

Value of multi-quadrants biopsy: Pooled analysis of 11 population-based cervical cancer screening studies
por: Zhao, Yuqian, et al.
Publicado: (2020)

The Potential of Adding Mammography to Handheld Ultrasound or Automated Breast Ultrasound to Reduce Unnecessary Biopsies in BI-RADS Ultrasound Category 4a: A Multicenter Hospital-Based Study in China
por: Ren, Wenhui, et al.
Publicado: (2023)

Epidemiologic and Health Economic Evaluation of Cervical Cancer Screening in Rural China
por: Zhao, Fei, et al.
Publicado: (2020)

Performance of cervical cancer screening and triage strategies among women living with HIV in China
por: Duan, Rufei, et al.
Publicado: (2021)

Economic evaluation of cervical cancer screening strategies in urban China
por: Ma, Li, et al.
Publicado: (2019)

Elimination of Cervical Cancer: Challenges Promoting the HPV Vaccine in China
por: Wei, Lihui, et al.
Publicado: (2021)

Naturally acquired HPV antibodies against subsequent homotypic infection: A large-scale prospective cohort study
por: Yao, Xingmei, et al.
Publicado: (2021)

Comment on “Will HPV vaccination prevent cervical cancer”
por: Zhang, Shaokai, et al.
Publicado: (2020)

Distribution of high-risk human papillomavirus genotype prevalence and attribution to cervical precancerous lesions in rural North China
por: Zhao, Shuang, et al.
Publicado: (2019)

Global guidelines for breast cancer screening: A systematic review()
por: Ren, Wenhui, et al.
Publicado: (2022)

Response to comment on: “Global guidelines for breast cancer screening: A systematic review”
por: Ren, Wenhui, et al.
Publicado: (2022)

Implementing the free HPV vaccination for adolescent girls aged below 14 in Shenzhen, Guangdong Province of China: experience, challenges, and lessons
por: Wu, Dadong, et al.
Publicado: (2023)

Effect of electronic health (eHealth) on quality of life in women with breast cancer: A systematic review and meta‐analysis of randomized controlled trials
por: Wen, Tianmeng, et al.
Publicado: (2023)

Impact of HPV-16/18 AS04-adjuvanted vaccine on preventing subsequent infection and disease after excision treatment: post-hoc analysis from a randomized controlled trial
por: Zhao, Shuang, et al.
Publicado: (2020)

The features of high-risk human papillomavirus infection in different female genital sites and impacts on HPV-based cervical cancer screening
por: Li, Tingyuan, et al.
Publicado: (2023)

Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Cervical Intraepithelial Neoplasia in Chinese Women Living With HIV
por: Feng, Min, et al.
Publicado: (2021)

Health and economic impact of HPV 16 and 18 vaccination and cervical cancer screening in India
por: Diaz, M, et al.
Publicado: (2008)

Cancer burden attributable to human papillomavirus infection by sex, cancer site, age, and geographical area in China
por: Duan, Rufei, et al.
Publicado: (2019)

The cost-effectiveness of implementing HPV testing for cervical cancer screening in El Salvador
por: Campos, Nicole G., et al.
Publicado: (2019)

HPV negative cervical cancers and primary HPV screening
por: Tjalma, WAA
Publicado: (2018)

Cervical cancer: Epidemiology, risk factors and screening
por: Zhang, Shaokai, et al.
Publicado: (2020)

Comparison of the performance of HPV DNA chip test and HPV PCR test in cervical cancer screening in rural China
por: Li, Zhi-Fang, et al.
Publicado: (2022)

Effectiveness Modelling and Economic Evaluation of Primary HPV Screening for Cervical Cancer Prevention in New Zealand
por: Lew, Jie-Bin, et al.
Publicado: (2016)

HPV and cervical cancer: screening or vaccination?
por: Bosch, F X, et al.
Publicado: (2008)

Now or later: Health impacts of delaying single‐dose HPV vaccine implementation in a high‐burden setting
por: Burger, Emily A., et al.
Publicado: (2022)

Understanding the Challenges of HPV-Based Cervical Screening: Development and Validation of HPV Testing and Self-Sampling Attitudes and Beliefs Scales
por: Tatar, Ovidiu, et al.
Publicado: (2023)

Yes! To Scaling Up Cervical Cancer Screening With Self-Collection: But the Cost of HPV Screening Must Be Reduced
por: Beddoe, Ann Marie
Publicado: (2021)

Introduction of HPV testing for cervical cancer screening in Central America: The Scale-Up project()
por: Holme, Francesca, et al.
Publicado: (2020)

Clinical Performance of Human Papillomavirus (HPV) Testing versus Cytology for Cervical Cancer Screening: Results of a Large Danish Implementation Study
por: Thomsen, Louise T, et al.
Publicado: (2020)

The challenges of colposcopy for cervical cancer screening in LMICs and solutions by artificial intelligence
por: Xue, Peng, et al.
Publicado: (2020)

The value of HPV genotypes combined with clinical indicators in the classification of cervical squamous cell carcinoma and adenocarcinoma
por: He, Zhimin, et al.
Publicado: (2022)

Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study
por: Brotherton, Julia M.L., et al.
Publicado: (2023)

Need for expanded HPV genotyping for cervical screening()
por: Cuzick, Jack, et al.
Publicado: (2016)

Cervical Cancer Screening and HPV Vaccination in Nepal
por: Baral, Gehanath, et al.
Publicado: (2023)

Maximizing the cost-effectiveness of cervical screening in the context of routine HPV vaccination by optimizing screening strategies with respect to vaccine uptake: a modeling analysis
por: Choi, Horace C. W., et al.
Publicado: (2023)

An Overview of HPV Screening Tests to Improve Access to Cervical Cancer Screening Amongst Underserved Populations: From Development to Implementation
por: Okunade, Kehinde S, et al.
Publicado: (2022)

Is It Time to Genotype Beyond HPV16 and HPV18 for Cervical Cancer Screening?
por: Chua, Brandon Wen Bing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_djvddjtrh2p6ors01vmd6vd56r